Skip to main content

MTRC is a leading provider of reimbursement, health economic and evidence synthesis services to the medical technologies industry in Europe. 

MTRC was established in 2017 in Stockholm.

What started as a small team of a few reimbursement consultants, has grown into a boutique consultancy offering more than twenty dedicated consultants and analysts in six European countries. We currently have an HEOR office in the United Kingdom (UK), a market access consultancy office in Spain and a contracting/billing office in Bulgaria.


Specializing in multi-country European projects, we proudly include more than 890 projects in 34 European countries as part of our portfolio.

Our team includes experienced clinical coders, reimbursement and HEOR analysts, and is complemented by affiliated senior reimbursement consultants from different major countries. Our analysts speak English, French, German, Italian, Spanish and Polish. We also have on-demand access to native speakers who are specialists in healthcare systems in other key regions of Europe (Scandinavia, the Netherlands, and Eastern European countries).

We are also probably the largest Med Tech market access consultancy in Europe, which helps us accumulate unique knowledge and insight

Since the very beginning, MTRC’s specialty was the medical technologies sector. While most other life science consultants spend 90% of their time on pharmaceutical projects, we do not perform any pharmaceutical projects, but dedicate 100% of our time to the area of medical technologies, so that our specialization results in higher-quality services at a lower cost.

Part of our mission and core values is our cost-effective approach to providing services. We understand the budgetary challenges of the med tech industry and can therefore offer a cost-effective approach to our specialised services. Fourteen percent (14%) of our current business comes from small to medium enterprises (SMEs) – a testament to our unique and personal approach to solving our clients’ budgetary challenges. Our prices are regarded as reasonable and generally affordable for the medical device industry (both corporations and SMEs).

One of our main focuses is on producing accurate analysis and reporting, strictly according to the timelines and expectations of our client. We are accredited by the United Kingdom Accreditation Service (UKAS) as an ISO 9001:2015 certified vendor. 

Our vision, mission, and core values

Vision

Our vision is a world with access to med tech innovations.

Mission

Our mission is to inform business decisions and support med tech industry in a cost-effective way to enable rapid and sustainable access to innovations for patients, healthcare systems, and society at large.

Values

In our daily work, we are guided by a set of core values:

  • We put the interests of the clients first
  • We do not compromise on quality
  • We take a pragmatic approach
  • We are attentive to details
  • We work in a cost-effective manner 

Our team

The team of experienced consultants and researchers with a deep understanding of both clinical aspects of medical care and organizational/financial frameworks in Europe

18
People
11
Medical doctors
5
PhDs
7
European languages
cvb
xzc
xzcczx
zxcb
zxcvbn
xcvb
xzcvbn
cvb
xcvb
cxvb
zsdxfcg
szdxfgcvn
cvcbvn
dfgb
xcvb
dfg
sfdfvbg
cdvfgb

Meet the founder

OB

Oleg Borisenko is the founder and Director of MTRC.

Oleg has fourteen years of experience in the field of med tech reimbursement. Prior to establishing MTRC, Oleg was the Director of Market Access and Health Economics at Synergus AB in Stockholm, Sweden.

Over the course of his professional career, Oleg has supervised several hundreds of projects, including reimbursement mappings and strategies, value dossiers, systematic literature reviews, health economic models, and within-trial economic evaluations. Oleg has the unique skill of combining both a high-level understanding of a broad range of topics, and in-depth knowledge and hands-on experience with major market access-related activities.

 

In the past, Oleg was an active contributor to both the Cochrane Acute Respiratory Infections, and Effective Practice and the Organisation of Health Care Review Groups. Currently, he is a member of the Editorial Board of one of the leading international health economic journals, the “Journal of Medical Economics” (Informa).

For several years, Oleg had held the position of Affiliated Researcher at the Department of Learning, Informatics, Management and Ethics at the Karolinska Institute in Stockholm, where he was involved in studies aimed at improving the Swedish healthcare system.

MTRC in numbers 

An extremely specialised boutique consultancy with a global impact

18
18
Full-time employees
893
893
Projects
221
221
Clients
17
17
Regular clients from the top 30 med tech companies
12%
12%
Of business comes from Small to Medium-sized Enterprises (SMEs)

Testimonials from our clients

Since 2017, we have accomplished more than 890 projects for more than 220 companies. The quality of our work translates into building long-term relationships with our clients: 78% of the business comes from repeat clients, and our Net Promoter Score (NPS) is 10 out of 10. While most of the projects are performed under strict NDAs, we are still delighted to share testimonials from some of our clients, representing both large corporations and start-ups. 

“MTRC is an expert in the market access of medical devices. They are updated about changes and know the realities that impact the business. They are fair and honest with their advice and trustworthy with discussions and deliverables. It is a pleasure to work with MTRC, whom we consider a reliable partner.“
Zenichi Ihara, Director, Health Economics and Reimbursement EMEA, CRM, EP, HF, Abbott
“MTRC takes time to fully understand our questions and objectives and delivers insightful, professional, and valuable results accordingly.”
Michael Morseon, Senior Director, Healthcare Economics & Market Access, Cooper Surgical
“Oleg and the team at MTRC provided us with a very comprehensive analysis with key sights and recommendations for a practical and feasible reimbursement approach for our product. MTRC took the time to understand our clinical area and brought clinical consultants on board during the activity for an in-depth understanding of our field of work. I recommend MTRC to my peers and the institutions we are affiliated with.”
Sarusha Pillay, Commercial Lead, pHetalSafe (pre-spinout team) at the University College Cork
“I have used the services of MTRC a number of times in different positions during my career and have found them to be a leading authority on Health Technology Assessment and Reimbursement marketing research, even for the most obscure of clinical case types. They are fast, efficient, transparent, professional, and the quality of their reporting is second to none. I highly recommend them as a research firm on anything reimbursement or HTA related for the European Continent.”
Michael van Driel, Vice President Global Business Development and General Manager, CBM Lifemotion
“Working with MTRC was a great experience. Their expertise and professionalism were evident in every step of the project. The team was highly responsive and delivered clear and timely results. I highly recommend MTRC for any project that requires a clear reimbursement strategy and local reimbursement analysis.”
Itay Jacob, VP Sales & Marketing, Mego Afek
“I’ve just completed my 2nd experience of collaboration with MTRC, both on the MedTech and Pharma reimbursement environment. I have come back to MTRC because of the speed of execution (compared to other vendors), the acumen in the preparatory work, and the accuracy of the report. I also very much value their insights on policy recommendations, helping me to navigate very complex reimbursement systems at the EU level. Definitely recommended!”
Andrea Minotto, Director Global Market Access, Bracco
“MTRC, led by Oleg Borisenko and his team, has been an invaluable partner to InVera Medical over the past several years. Their expertise in European reimbursement, market analysis, and budget impact assessments has consistently provided us with high-quality insights that have been crucial for our strategic decisions. The team's clear communication, reliability, and ability to deliver on time have made them a trusted consultant in our journey. We highly recommend MTRC for their exceptional service and expertise.”
Stephen Cox, CEO, Co-Founder, InVera Medical
"MTRC exceeded our expectations for our university medical device technology. Beyond delivering expert reimbursement analysis and market access strategies for our target geographies, they proactively identified additional optimal markets we hadn't considered. Their team's accessibility and patience in explaining complex analyses made them true partners in our project's development. For anyone seeking thorough, strategic market access guidance, MTRC is an outstanding choice."
Justina Ugwah, Commercial lead, CLISTEPROBE, Tyndall National Institute
"Invizius is a clinical-stage biotech developing second-generation complement therapies addressing serious unmet needs for patients on extracorporeal circuit therapies. For our company to be successful, it is important to develop reimbursement solutions and market access strategies to allow for fast and widespread adoption of our breakthrough technology. MTRC provided us with a clear market access reimbursement strategy specifically designed around the specificities and patient benefits of our lead product H-Guard. This individualized approach is unique among consultants and has proven invaluable. We would highly recommend MTRC for anyone seeking advice on European market access."
Eric Beard, Chairman, Invizius

Thought Leadership

Market Access Monitor

Service of monitoring key reimbursement and HTA developments for medical devices, in-vitro diagnostic tests, and digital technologies in Europe and globally.

Learn more

Free EU reimbursement news and Publications Digest

Bi-weekly newsletter with 10 key reimbursement/HTA news items and summaries of the most important peer-reviewed publications. Access news from as far back as 2017. 

Learn more

Analytical White Papers

Free analytical and research White Papers on the topic of reimbursement, HTA and evidence requirements for medical devices and IVD tests in Europe.

Learn more

Knowledge Zone

Brief summaries of the market access landscape for medical technologies and in-vitro diagnostic tests in European countries.

Learn more

Knowledge Zone – Technologies

Brief summaries of the market access landscape and challenges for individual types of medical technologies in Europe

Learn more

Report on innovative payment schemes for EU association Med Tech Europe

In 2022 Med Tech Europe and MTRC developed a comprehensive report on innovative payment schemes in European countries.

Learn more

Educational materials on market access

MTRC offers the most comprehensive repository of training presentations on the topic of med tech market access. We offer both general introductory seminars (including pre-recorded webinars) and more than 70 country-specific seminars. 

Learn more

Youtube channel “Market Access Insider”

In 2019 MTRC launched a channel dedicated to the topic of market access for medical devices. See our interviews with different stakeholders from EU countries.

Learn more

Get in touch

Contact us to discuss your needs and learn about our services